Citigroup »

Outlook Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.6k 24k 0.39
2023-09-30 $64 289 0.22
2022-12-31 $861 798 1.08
2022-09-30 $2.0k 1.8k 1.12
2021-12-31 $31k 23k 1.35